Roswell Park introduces "Tactiva Therapeutics" as new Biotech Spinoff Comapny

Posted at 12:28 PM, Feb 03, 2017
and last updated 2017-02-03 12:28:37-05

Lieutenant Governor Kathy Hochul, Dr. Candace Johnson and a special team of doctors at Roswell Park announced the launch of a new innovative Immunotherapy Biotech Company called, Tactiva Therapeutics in front of a packed house inside Roswell's Research Center.

Tactiva will develop the latest science to lead even more effective approaches at fighting and treating the most aggressive forms of cancer. In addition, the company will bring 18 new jobs to Western New York, supporting the continued growth of the Medical Corridor. 

The company will focus on implementing a unique approach using pre-existing immune cells drawn from blood and genetically multiplying and strengthening them before injecting them back into the patient to fight cancer cells. 

Clinical trials are expected to begin within the next year.